March 7, 2023 Intelligent Bio Solutions Inc. Announces Proposed Public Offering March 1, 2023 Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement February 16, 2023 Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge February 14, 2023 Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights February 9, 2023 Intelligent Bio Solutions Inc. Announces Reverse Stock Split February 7, 2023 Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing January 31, 2023 Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests January 23, 2023 Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development December 22, 2022 Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering December 21, 2022 Intelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of Stockholders
February 16, 2023 Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge
February 14, 2023 Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights
February 7, 2023 Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing
January 31, 2023 Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests
December 21, 2022 Intelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of Stockholders
